Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Option-based deals: How biotechs and big pharmas share R&D risks
Option-based deals: How biotechs and big pharmas share R&D risks
Option-based deals: How biotechs and big pharmas share R&D risks
Submitted by
admin
on October 14, 2011 - 11:18am
Source:
Med City
News Tags:
options
R&D
biotech
Big Pharma
Targacept
AstraZeneca
Headline:
Option-based deals: How biotechs and big pharmas share R&D risks
Do Not Allow Advertisers to Use My Personal information
